pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

New tumor atlas reveals why colorectal cancer is more aggressive in younger patients

Oct 29, 2026·read at STAT ↗Positive

Researchers have created a new atlas that catalogs 189 colorectal tumor samples from patients aged in their 20s to 90s, aiming to clarify why cancers that arise early are harder to treat.

The collection, described in a Nature Medicine paper by Kimmie Ng and colleagues, compares molecular features of early-onset tumors (under 50) with those from older adults.

Analysis shows distinct biological signatures in tumors from the youngest patients, which may explain their tendency to present at later stages and respond less well to standard therapies.

The findings provide a resource for future studies and could guide the development of age-specific treatment strategies, potentially improving outcomes for younger colorectal cancer patients.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous”

read at STAT ↗
503 words · retrieved 50m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Dana-Farber Cancer Institute Inc
topics
Oncology14Colorectal Cancer6Multiple Myeloma

related stories

  • Oct 13Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEsFierce Biotech
  • Oct 1Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor dataFierce Biotech
  • Aug 17Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vagueFierce Biotech
  • Jul 13Agenus surges on study pivot; Apnimed lines up an IPOBioPharma Dive
  • May 29Bristol Myers unveils data for one of its next-gen blood cancer drugsBioPharma Dive